Hahaha - gets a ‘sniffle’ and makes the comparison with a self-treating cancer sufferer which seems a little obtuse to me.
I’m not sure what illness James suffered from - but I wish him well and a speedy recovery.
Luckily the market seems to agree with James and his management of KZA and it’s new direction and recent results.
I hope the management of NOX can achieve something similar for NOX holders as there has been a cancer eating their SP and it could do with some form of self-treatment.
KZA Price at posting:
60.0¢ Sentiment: Buy Disclosure: Held